Insights on cyclophosphamide metabolism and anticancer mechanism of action : A computational study

© 2023 The Authors. Journal of Computational Chemistry published by Wiley Periodicals LLC.

Bibliographische Detailangaben
Veröffentlicht in:Journal of computational chemistry. - 1984. - 45(2024), 10 vom: 15. März, Seite 663-670
1. Verfasser: Dabbish, Eslam (VerfasserIn)
Weitere Verfasser: Scoditti, Stefano, Shehata, Mohammed N I, Ritacco, Ida, Ibrahim, Mahmoud A A, Shoeib, Tamer, Sicilia, Emilia
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Journal of computational chemistry
Schlagworte:Journal Article DFT DNA alkylating agents cyclophosphamide Cyclophosphamide 8N3DW7272P Acrolein 7864XYD3JJ 9007-49-2
LEADER 01000caa a22002652 4500
001 NLM365792144
003 DE-627
005 20240304232121.0
007 cr uuu---uuuuu
008 231226s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/jcc.27280  |2 doi 
028 5 2 |a pubmed24n1316.xml 
035 |a (DE-627)NLM365792144 
035 |a (NLM)38088485 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Dabbish, Eslam  |e verfasserin  |4 aut 
245 1 0 |a Insights on cyclophosphamide metabolism and anticancer mechanism of action  |b A computational study 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.03.2024 
500 |a Date Revised 04.03.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2023 The Authors. Journal of Computational Chemistry published by Wiley Periodicals LLC. 
520 |a The oxazaphosphorine cyclophosphamide (CP) is a DNA-alkylating agent commonly used in cancer chemotherapy. This anticancer agent is administered as a prodrug activated by a liver cytochrome P450-catalyzed 4-hydroxylation reaction that yields the active, cytotoxic metabolite. The primary metabolite, 4-hydroxycyclophosphamide, equilibrates with the ring-open aldophosphamide that undergoes β-elimination to yield the therapeutically active DNA cross-linking phosphoramide mustard and the byproduct acrolein. The present paper presents a DFT investigation of the different metabolic phases and an insight into the mechanism by which CP exerts its cytotoxic action. A detailed computational analysis of the energy profiles describing all the involved transformations and the mechanism of DNA alkylation is given with the aim to contribute to an increase of knowledge that, after more than 60 years of unsuccessful attempts, can lead to the design and development of a new generation of oxazaphosphorines 
650 4 |a Journal Article 
650 4 |a DFT 
650 4 |a DNA 
650 4 |a alkylating agents 
650 4 |a cyclophosphamide 
650 7 |a Cyclophosphamide  |2 NLM 
650 7 |a 8N3DW7272P  |2 NLM 
650 7 |a Acrolein  |2 NLM 
650 7 |a 7864XYD3JJ  |2 NLM 
650 7 |a DNA  |2 NLM 
650 7 |a 9007-49-2  |2 NLM 
700 1 |a Scoditti, Stefano  |e verfasserin  |4 aut 
700 1 |a Shehata, Mohammed N I  |e verfasserin  |4 aut 
700 1 |a Ritacco, Ida  |e verfasserin  |4 aut 
700 1 |a Ibrahim, Mahmoud A A  |e verfasserin  |4 aut 
700 1 |a Shoeib, Tamer  |e verfasserin  |4 aut 
700 1 |a Sicilia, Emilia  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of computational chemistry  |d 1984  |g 45(2024), 10 vom: 15. März, Seite 663-670  |w (DE-627)NLM098138448  |x 1096-987X  |7 nnns 
773 1 8 |g volume:45  |g year:2024  |g number:10  |g day:15  |g month:03  |g pages:663-670 
856 4 0 |u http://dx.doi.org/10.1002/jcc.27280  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 45  |j 2024  |e 10  |b 15  |c 03  |h 663-670